ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,120 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $365,852 | +66.5% | 4,691 | +44.6% | 0.08% | +61.2% |
| Q1 2024 | $219,781 | +10.6% | 3,244 | +9.9% | 0.05% | +2.1% |
| Q4 2023 | $198,750 | +61.7% | 2,951 | +62.6% | 0.05% | +50.0% |
| Q3 2023 | $122,912 | -18.3% | 1,815 | -13.7% | 0.03% | -20.0% |
| Q2 2023 | $150,512 | +33.5% | 2,103 | +29.5% | 0.04% | +29.0% |
| Q1 2023 | $112,722 | +12.2% | 1,624 | +9.6% | 0.03% | +6.9% |
| Q4 2022 | $100,480 | +43.5% | 1,482 | +16.1% | 0.03% | +38.1% |
| Q3 2022 | $70,000 | +45.8% | 1,277 | +74.2% | 0.02% | +50.0% |
| Q2 2022 | $48,000 | +220.0% | 733 | +227.2% | 0.01% | +250.0% |
| Q1 2022 | $15,000 | +15.4% | 224 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $13,000 | -27.8% | 224 | -24.6% | 0.00% | -40.0% |
| Q3 2021 | $18,000 | 0.0% | 297 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $18,000 | +12.5% | 297 | -10.8% | 0.01% | +25.0% |
| Q1 2021 | $16,000 | +433.3% | 333 | +356.2% | 0.00% | +300.0% |
| Q4 2020 | $3,000 | -50.0% | 73 | -42.5% | 0.00% | -50.0% |
| Q3 2020 | $6,000 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |